MUFG Securities EMEA plc Has $1.53 Million Position in GE HealthCare Technologies Inc. $GEHC

MUFG Securities EMEA plc increased its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 113.7% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 18,674 shares of the company’s stock after buying an additional 9,935 shares during the quarter. MUFG Securities EMEA plc’s holdings in GE HealthCare Technologies were worth $1,532,000 at the end of the most recent reporting period.

A number of other large investors have also added to or reduced their stakes in GEHC. Laurel Wealth Advisors LLC acquired a new stake in GE HealthCare Technologies during the fourth quarter worth approximately $26,000. Optima Capital LLC acquired a new stake in GE HealthCare Technologies during the fourth quarter worth approximately $27,000. Godfrey Financial Associates Inc. acquired a new stake in GE HealthCare Technologies during the fourth quarter worth approximately $27,000. Montag A & Associates Inc. grew its position in GE HealthCare Technologies by 105.4% during the fourth quarter. Montag A & Associates Inc. now owns 341 shares of the company’s stock worth $28,000 after buying an additional 175 shares in the last quarter. Finally, Maseco LLP acquired a new stake in GE HealthCare Technologies during the fourth quarter worth approximately $29,000. Institutional investors and hedge funds own 82.06% of the company’s stock.

Insider Buying and Selling

In other news, CEO Peter J. Arduini purchased 4,169 shares of the company’s stock in a transaction dated Thursday, April 30th. The stock was bought at an average cost of $59.92 per share, for a total transaction of $249,806.48. Following the purchase, the chief executive officer owned 259,424 shares of the company’s stock, valued at approximately $15,544,686.08. The trade was a 1.63% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Kevin Lobo purchased 10,000 shares of the company’s stock in a transaction dated Friday, May 22nd. The stock was purchased at an average price of $64.18 per share, with a total value of $641,800.00. Following the completion of the purchase, the director directly owned 14,363 shares in the company, valued at $921,817.34. The trade was a 229.20% increase in their position. The SEC filing for this purchase provides additional information. Insiders purchased 21,847 shares of company stock worth $1,361,355 in the last ninety days. Insiders own 0.36% of the company’s stock.

Analyst Ratings Changes

A number of brokerages recently issued reports on GEHC. Argus reduced their price target on GE HealthCare Technologies from $95.00 to $80.00 and set a “buy” rating on the stock in a research report on Tuesday, May 19th. Citigroup reduced their price target on GE HealthCare Technologies from $80.00 to $65.00 and set a “neutral” rating on the stock in a research report on Thursday, April 30th. UBS Group raised GE HealthCare Technologies from a “sell” rating to a “neutral” rating and reduced their price target for the stock from $75.00 to $69.00 in a research report on Thursday, May 21st. HSBC reduced their target price on GE HealthCare Technologies from $100.00 to $90.00 in a report on Thursday, April 30th. Finally, JPMorgan Chase & Co. reduced their target price on GE HealthCare Technologies from $80.00 to $65.00 and set a “neutral” rating on the stock in a report on Thursday, April 30th. Nine analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company. Based on data from MarketBeat, GE HealthCare Technologies currently has an average rating of “Moderate Buy” and an average price target of $80.21.

GE HealthCare Technologies Trading Down 1.1%

Shares of GEHC stock opened at $61.99 on Wednesday. The stock’s fifty day moving average price is $67.53 and its two-hundred day moving average price is $75.81. The company has a market cap of $28.20 billion, a PE ratio of 14.83, a P/E/G ratio of 1.41 and a beta of 0.74. GE HealthCare Technologies Inc. has a fifty-two week low of $58.75 and a fifty-two week high of $89.77. The company has a debt-to-equity ratio of 0.95, a quick ratio of 0.95 and a current ratio of 1.22.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its earnings results on Wednesday, April 29th. The company reported $0.99 earnings per share for the quarter, missing analysts’ consensus estimates of $1.07 by ($0.08). The business had revenue of $5.13 billion during the quarter, compared to analyst estimates of $5.04 billion. GE HealthCare Technologies had a net margin of 9.10% and a return on equity of 20.46%. The company’s revenue for the quarter was up 7.4% compared to the same quarter last year. During the same period in the prior year, the business posted $1.01 EPS. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. Equities analysts predict that GE HealthCare Technologies Inc. will post 4.89 EPS for the current fiscal year.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.